These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2920479)

  • 1. The pharmacokinetics and tissue penetration of the fluoroquinolones.
    Bergeron MG
    Clin Invest Med; 1989 Feb; 12(1):20-7. PubMed ID: 2920479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of the quinolones in volunteers: a proposed dosing schedule.
    Wise R; Griggs D; Andrews JM
    Rev Infect Dis; 1988; 10 Suppl 1():S83-9. PubMed ID: 3162327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pharmacokinetics of oral quinolones (norfloxacin, ciprofloxacin, ofloxacin).
    Alestig K
    Scand J Infect Dis Suppl; 1990; 68():19-22. PubMed ID: 2218417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic considerations in quinolone therapy.
    Nightingale CH
    Pharmacotherapy; 1993; 13(2 Pt 2):34S-38S. PubMed ID: 8474936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions.
    Sörgel F; Kinzig M
    Am J Med; 1993 Mar; 94(3A):56S-69S. PubMed ID: 8383921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-tissue distribution relationship based on physiological pharmacokinetics for NY-198, a new antimicrobial agent, and the related pyridonecarboxylic acids.
    Okezaki E; Terasaki T; Nakamura M; Nagata O; Kato H; Tsuji A
    Drug Metab Dispos; 1988; 16(6):865-74. PubMed ID: 2907467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA
    Am J Med; 1992 Apr; 92(4A):18S-21S. PubMed ID: 1316065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of quinolones: newer aspects.
    Wolfson JS; Hooper DC
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):267-74. PubMed ID: 1864287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of quinolones in renal insufficiency.
    Fillastre JP; Leroy A; Moulin B; Dhib M; Borsa-Lebas F; Humbert G
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():51-60. PubMed ID: 2124213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of enrofloxacin in adult horses and concentration of the drug in serum, body fluids, and endometrial tissues after repeated intragastrically administered doses.
    Giguère S; Sweeney RW; Bélanger M
    Am J Vet Res; 1996 Jul; 57(7):1025-30. PubMed ID: 8807015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental toxicity of fleroxacin and comparative pharmacokinetics of four fluoroquinolones in the cynomolgus macaque (Macaca fascicularis).
    Hummler H; Richter WF; Hendrickx AG
    Toxicol Appl Pharmacol; 1993 Sep; 122(1):34-45. PubMed ID: 8397453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative brain microdialysis study on the mechanism of quinolones distribution in the central nervous system.
    Ooie T; Terasaki T; Suzuki H; Sugiyama Y
    Drug Metab Dispos; 1997 Jul; 25(7):784-9. PubMed ID: 9224772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of fluorinated 4-quinolones in the aged.
    Norrby SR; Ljungberg B
    Rev Infect Dis; 1989; 11 Suppl 5():S1102-6. PubMed ID: 2672244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolone pharmacokinetics and metabolism.
    Lode H; Höffken G; Boeckk M; Deppermann N; Borner K; Koeppe P
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():41-9. PubMed ID: 2124212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of in vitro activities of the fluoroquinolones to their in vivo efficacies.
    Fernandes PB; Swanson RN
    Drugs Exp Clin Res; 1988; 14(6):375-8. PubMed ID: 3145851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis.
    Montgomery MJ; Beringer PM; Aminimanizani A; Louie SG; Shapiro BJ; Jelliffe R; Gill MA
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of prulifloxacin. 1st communication: absorption, distribution and excretion in rats, dogs and monkeys after a single administration.
    Okuyama Y; Momota K; Morino A
    Arzneimittelforschung; 1997 Mar; 47(3):276-84. PubMed ID: 9105546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats.
    Delon A; Huguet F; Courtois P; Vierfond JM; Bouquet S; Couet W
    J Pharmacol Exp Ther; 1997 Feb; 280(2):983-7. PubMed ID: 9023315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative pharmacokinetics of five quinolones.
    Wise R; Lister D; McNulty CA; Griggs D; Andrews JM
    J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of the des-F(6)-quinolone garenoxacin in plasma and joint cartilage of immature rats.
    Kastner M; Rahm U; Baumann-Wilschke I; Bello A; Stahlmann R
    Arch Toxicol; 2004 Feb; 78(2):61-7. PubMed ID: 14661070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.